Inogen to Report Third Quarter 2023 Financial Results on November 7, 2023

Rhea-AI Summary

Inogen, Inc. will report Q3 2023 financial results on November 7, 2023.

Positive

• Inogen, Inc. will report their Q3 2023 financial results after the market closes on November 7, 2023.

Negative

• None.

GOLETA, Calif.--(BUSINESS WIRE)-- Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report third quarter 2023 financial results after the market closes on Tuesday, November 7, 2023. On the same day, the Company will host a conference call at 2:00 p.m. PT / 5:00 p.m. ET.

Individuals interested in listening to the conference call may do so by dialing:

US domestic callers (877) 841-3961
Non-US callers (201) 689-8589

Please reference Inogen to join the call. To listen to a live webcast, please visit the Investor Relations section of Inogen's website at: http://investor.inogen.com/. This webcast will also be archived on the website for 6 months.

A replay of the call will be available approximately three hours after the live webcast ends and will be accessible through November 14, 2023. To access the replay, dial (877) 660-6853 or (201) 612-7415 and reference Conference ID: 13740970.

Inogen has used, and intends to continue to use, its Investor Relations website, http://investor.inogen.com/, as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. For more information, visit http://investor.inogen.com/.

About Inogen

Inogen, Inc. (Nasdaq: INGN) is a leading global medical technology company offering innovative respiratory products for use in the homecare setting. Inogen supports patient respiratory care by developing, manufacturing, and marketing innovative best-in-class portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Inogen partners with patients, prescribers, home medical equipment providers, and distributors to make its oxygen therapy products widely available allowing patients the chance to remain ambulatory while managing the impact of their disease.

For more information, please visit www.inogen.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231010533815/en/

ir@inogen.net

Source: Inogen, Inc.

FAQ

When will Inogen, Inc. report their Q3 2023 financial results?

Inogen, Inc. will report their Q3 2023 financial results on November 7, 2023.

What time is the conference call for Inogen, Inc.'s Q3 2023 financial results?

The conference call for Inogen, Inc.'s Q3 2023 financial results will be held at 2:00 p.m. PT / 5:00 p.m. ET on November 7, 2023.

How can I listen to the conference call for Inogen, Inc.'s Q3 2023 financial results?

To listen to the conference call, dial (877) 841-3961 for US domestic callers or (201) 689-8589 for non-US callers and reference Inogen.

Will there be a replay of the conference call for Inogen, Inc.'s Q3 2023 financial results?

Yes, a replay of the conference call will be available approximately three hours after the live webcast ends and can be accessed by dialing (877) 660-6853 or (201) 612-7415 and referencing Conference ID: 13740970.

Where can I find more information about Inogen, Inc.'s Q3 2023 financial results?

For more information, visit the Investor Relations section of Inogen's website at http://investor.inogen.com/.